Aster Capital Management’s Aktis Oncology AKTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$14.6K Buy
+748
New +$18.2K 0.01% 735

Other funds holding AKTS

Aster Capital Management's AKTS Position: Q3 2026 in Review

Aster Capital Management opened a new position in Aktis Oncology (AKTS) in Q3 2026: 748 shares worth $14.6K. The stake represents 0.01% of the portfolio and ranks #735 among its holdings.

125 funds tracked by Wall St. Rank hold AKTS as of Q3 2026.

  • Aster Capital Management held 748 shares of Aktis Oncology worth $14.6K as of Q3 2026.
  • Aktis Oncology was a new Aster Capital Management position in Q3 2026.
  • Aktis Oncology made up 0.01% of Aster Capital Management's portfolio in Q3 2026, its #735 holding.
  • 125 funds tracked by Wall St. Rank held Aktis Oncology as of Q3 2026.

Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.